HUP0103160A3 - Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor - Google Patents
Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitorInfo
- Publication number
- HUP0103160A3 HUP0103160A3 HU0103160A HUP0103160A HUP0103160A3 HU P0103160 A3 HUP0103160 A3 HU P0103160A3 HU 0103160 A HU0103160 A HU 0103160A HU P0103160 A HUP0103160 A HU P0103160A HU P0103160 A3 HUP0103160 A3 HU P0103160A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- pulmonary diseases
- pde4 inhibitor
- treating pulmonary
- diseases containing
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title 1
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9797398P | 1998-08-26 | 1998-08-26 | |
PCT/US1999/019332 WO2000012078A1 (en) | 1998-08-26 | 1999-08-24 | Therapies for treating pulmonary diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0103160A2 HUP0103160A2 (hu) | 2002-01-28 |
HUP0103160A3 true HUP0103160A3 (en) | 2002-11-28 |
Family
ID=22266001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0103160A HUP0103160A3 (en) | 1998-08-26 | 1999-08-24 | Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor |
Country Status (21)
Country | Link |
---|---|
US (2) | US6288118B1 (hu) |
EP (1) | EP1107747A4 (hu) |
JP (1) | JP2002523452A (hu) |
KR (1) | KR20010072931A (hu) |
CN (1) | CN1314811A (hu) |
AR (1) | AR022072A1 (hu) |
AU (1) | AU754379B2 (hu) |
BR (1) | BR9913152A (hu) |
CA (1) | CA2341488A1 (hu) |
CZ (1) | CZ293735B6 (hu) |
DZ (1) | DZ2876A1 (hu) |
HU (1) | HUP0103160A3 (hu) |
IL (1) | IL141335A0 (hu) |
MA (1) | MA26302A1 (hu) |
MY (1) | MY126544A (hu) |
NO (1) | NO20010882D0 (hu) |
NZ (1) | NZ527232A (hu) |
PE (1) | PE20001032A1 (hu) |
PL (1) | PL346271A1 (hu) |
TR (1) | TR200100500T2 (hu) |
WO (1) | WO2000012078A1 (hu) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6525018B1 (en) * | 1999-05-17 | 2003-02-25 | The General Hospital Corp. | Treating eye disorders using intestinal trefoil proteins |
US6624181B1 (en) | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
US20030186882A1 (en) * | 2001-07-31 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating and preventing distal bowel lesions |
US20030185838A1 (en) * | 2001-11-28 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating lesions of the respiratory epithelium |
IL141335A0 (en) * | 1998-08-26 | 2002-03-10 | Smithkline Beecham Corp | Therapies for treating pulmonary diseases |
US8933032B2 (en) | 1998-10-20 | 2015-01-13 | Children's Hospital Medical Center | Surfactant protein D for the treatment of disorders associated with lung injury |
EA006685B1 (ru) * | 1999-08-21 | 2006-02-24 | Алтана Фарма Аг | Синергетическая композиция |
MXPA02012042A (es) | 2000-06-05 | 2004-08-19 | Altana Pharma Ag | Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4. |
US20060189526A1 (en) * | 2002-04-24 | 2006-08-24 | Podolsky Daniel K | Compositions containing an intestinal trefoil peptide and a mucoadhesive |
US20040171544A1 (en) * | 2001-04-24 | 2004-09-02 | Barker Nicholas P. | Trefoil domain-containing polypeptides and uses thereof |
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
US20030105016A1 (en) * | 2001-09-06 | 2003-06-05 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
US20030181384A1 (en) * | 2001-09-06 | 2003-09-25 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
JP2005508937A (ja) * | 2001-10-05 | 2005-04-07 | ザ ジェネラル ホスピタル コーポレーション | 皮膚病変を治療するための方法および組成物 |
US20030185839A1 (en) * | 2001-10-05 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating dermal lesions |
US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
CN1617739A (zh) * | 2001-11-28 | 2005-05-18 | 综合医院公司 | 用于治疗呼吸道上皮病变的方法和组合物 |
GB0129395D0 (en) * | 2001-12-07 | 2002-01-30 | Pfizer Ltd | Pharmaceutical combination |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
JP2005527547A (ja) * | 2002-03-26 | 2005-09-15 | ザ ジェネラル ホスピタル コーポレーション | トレフォイル・ペプチドを使用した組み合わせ療法 |
US20050222193A1 (en) * | 2002-05-07 | 2005-10-06 | Guido Hanauer | Novel combination for the treatment of airway disorders |
DE10220459A1 (de) * | 2002-05-07 | 2003-11-27 | Byk Gulden Lomberg Chem Fab | Neue Kombination zur Behandlung von Atemwegserkrankungen |
NZ536918A (en) * | 2002-05-07 | 2006-09-29 | Altana Pharma Ag | Combination of pantoprazole and a respiratory agent for the treatment of respiratory diseases |
DE10220458A1 (de) * | 2002-05-07 | 2003-11-27 | Altana Pharma Ag | Kombination zur Behandlung von Atemwegserkrankungen |
US20060188471A1 (en) * | 2002-10-31 | 2006-08-24 | Podolsky Daniel K | Methods of treating epithelial lesions |
JP2006508994A (ja) * | 2002-11-27 | 2006-03-16 | アルタナ ファルマ アクチエンゲゼルシャフト | ロフルミラスト及びホルモテロールを含有する新規の相乗組合せ |
AU2003288169B8 (en) * | 2002-11-27 | 2010-08-26 | Astrazeneca Ab | Synergistic combination comprising roflumilast and (R,R) -formoterol |
ME00524B (me) | 2003-03-10 | 2011-10-10 | Astrazeneca Ab | Novi postupak za dobijanje roflumilasta |
JPWO2004087151A1 (ja) * | 2003-03-31 | 2006-06-29 | 協和醗酵工業株式会社 | 医薬組成物 |
SE527200C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av formaterol och fluticason |
JP2008502699A (ja) * | 2004-06-14 | 2008-01-31 | セプラコール・インコーポレイテッド | 肺疾患治療方法、及びそのための組成物 |
AU2005254096A1 (en) * | 2004-06-14 | 2005-12-29 | Sepracor Inc. | Methods of using albuterol and calcium activated potassium channel openers |
WO2006097456A1 (en) | 2005-03-16 | 2006-09-21 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
DE102005030733A1 (de) * | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
AR066016A1 (es) * | 2007-04-11 | 2009-07-15 | Alcon Res Ltd | Uso de un inhibidor del tnf alfa junto con una antihistamina para tratar la rinitis alergica y la conjuntivitis alergica |
KR101815716B1 (ko) * | 2009-04-22 | 2018-01-05 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 만성 폐쇄성 폐 질환 및 천식의 치료에 사용하기 위한 조성물 |
CN102548536A (zh) * | 2009-10-01 | 2012-07-04 | 爱尔康研究有限公司 | 奥洛他定组合物及其用途 |
KR101035488B1 (ko) * | 2009-10-05 | 2011-05-20 | 숭실대학교산학협력단 | 자동차 블랙박스 영상물 수집 방법 |
WO2011056561A1 (en) | 2009-10-27 | 2011-05-12 | Beth Israel Deaconess Medical Center | Methods and compositions for the generation and use of conformation-specific antibodies |
EP2569285A1 (en) * | 2010-05-10 | 2013-03-20 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
WO2012149334A2 (en) | 2011-04-27 | 2012-11-01 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
US10433624B2 (en) * | 2015-03-26 | 2019-10-08 | Nike, Inc. | Duffel bag |
WO2019157144A1 (en) | 2018-02-07 | 2019-08-15 | Duke University | System and method for homogenous gpcr phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791025A (fr) | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
GB1457873A (en) | 1973-01-04 | 1976-12-08 | Allen & Hanburys Ltd | Imidazotriazines |
FR2390164A1 (fr) | 1977-05-13 | 1978-12-08 | Blanie Paul | Association a action anti-asthmatique |
US5602110A (en) | 1994-08-31 | 1997-02-11 | Case Western Reserve University | Method and composition for treating cystic fibrosis |
FR2753706B1 (fr) | 1996-09-20 | 1998-10-30 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
FR2753969B1 (fr) * | 1996-09-27 | 1998-10-30 | Adir | Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE59814173D1 (de) * | 1997-02-28 | 2008-04-03 | Nycomed Gmbh | Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse-agonisten |
US5858694A (en) | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
IL141335A0 (en) * | 1998-08-26 | 2002-03-10 | Smithkline Beecham Corp | Therapies for treating pulmonary diseases |
-
1999
- 1999-08-24 IL IL14133599A patent/IL141335A0/xx unknown
- 1999-08-24 CN CN99810111A patent/CN1314811A/zh active Pending
- 1999-08-24 TR TR2001/00500T patent/TR200100500T2/xx unknown
- 1999-08-24 AU AU54939/99A patent/AU754379B2/en not_active Ceased
- 1999-08-24 EP EP99941248A patent/EP1107747A4/en not_active Withdrawn
- 1999-08-24 HU HU0103160A patent/HUP0103160A3/hu unknown
- 1999-08-24 JP JP2000567196A patent/JP2002523452A/ja active Pending
- 1999-08-24 PL PL99346271A patent/PL346271A1/xx unknown
- 1999-08-24 CA CA002341488A patent/CA2341488A1/en not_active Abandoned
- 1999-08-24 KR KR1020017002358A patent/KR20010072931A/ko not_active Application Discontinuation
- 1999-08-24 US US09/763,516 patent/US6288118B1/en not_active Expired - Fee Related
- 1999-08-24 BR BR9913152-8A patent/BR9913152A/pt not_active IP Right Cessation
- 1999-08-24 DZ DZ990176A patent/DZ2876A1/xx active
- 1999-08-24 NZ NZ527232A patent/NZ527232A/en unknown
- 1999-08-24 WO PCT/US1999/019332 patent/WO2000012078A1/en not_active Application Discontinuation
- 1999-08-24 MY MYPI99003615A patent/MY126544A/en unknown
- 1999-08-24 CZ CZ2001692A patent/CZ293735B6/cs not_active IP Right Cessation
- 1999-08-25 MA MA25745A patent/MA26302A1/fr unknown
- 1999-08-25 PE PE1999000856A patent/PE20001032A1/es not_active Application Discontinuation
- 1999-09-03 AR ARP990104234A patent/AR022072A1/es not_active Application Discontinuation
-
2001
- 2001-02-21 NO NO20010882A patent/NO20010882D0/no not_active Application Discontinuation
- 2001-08-20 US US09/933,455 patent/US6555583B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TR200100500T2 (tr) | 2001-06-21 |
US6555583B2 (en) | 2003-04-29 |
AU5493999A (en) | 2000-03-21 |
KR20010072931A (ko) | 2001-07-31 |
US20010056122A1 (en) | 2001-12-27 |
CZ293735B6 (cs) | 2004-07-14 |
DZ2876A1 (fr) | 2003-12-15 |
EP1107747A1 (en) | 2001-06-20 |
AU754379B2 (en) | 2002-11-14 |
MY126544A (en) | 2006-10-31 |
US6288118B1 (en) | 2001-09-11 |
WO2000012078A1 (en) | 2000-03-09 |
NO20010882L (no) | 2001-02-21 |
NO20010882D0 (no) | 2001-02-21 |
AR022072A1 (es) | 2002-09-04 |
NZ527232A (en) | 2005-03-24 |
MA26302A1 (fr) | 2004-10-01 |
BR9913152A (pt) | 2001-05-15 |
HUP0103160A2 (hu) | 2002-01-28 |
EP1107747A4 (en) | 2003-04-23 |
CZ2001692A3 (cs) | 2002-02-13 |
PE20001032A1 (es) | 2000-11-10 |
PL346271A1 (en) | 2002-01-28 |
CN1314811A (zh) | 2001-09-26 |
JP2002523452A (ja) | 2002-07-30 |
CA2341488A1 (en) | 2000-03-09 |
IL141335A0 (en) | 2002-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103160A3 (en) | Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor | |
AU4025599A (en) | Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases | |
HUP0004211A3 (en) | Use of pde-5 inhibitors for the preparation of pharmaceutical compositions treating pulmonary hypertension | |
HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP9901606A2 (en) | Pharmaceutical compositions comprising sildenaphil | |
HUP0103507A3 (en) | Pharmaceutical compositions comprising 2-quinolones | |
GB9827996D0 (en) | Pharmaceutical Compositions | |
EP1133230A4 (en) | DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS | |
IL150390A0 (en) | Pharmaceutical compositions containing diacerein for treating psoriasis | |
EP0938901A4 (en) | MEDICINAL COMPOSITIONS FOR TREATING HEPATIC CONDITIONS | |
HUP0400654A3 (en) | Substituted 8-arylquinoline phosphodiesterase 4 inhibitors and pharmaceutical compositions containing them | |
GB9809213D0 (en) | Pharmaceutical compositions | |
HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP0401805A3 (en) | Compounds suitable for treating pulmonary diseases | |
HUP0003679A3 (en) | Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases | |
HUP0203152A3 (en) | Method and compositions for treating pulmonary diseases | |
GB9803521D0 (en) | New compounds and pharmaceutical compositions thereof | |
ZA977874B (en) | Pharmaceutical compositions for treating viral diseases | |
EP1084108A4 (en) | SPLA 2 INHIBITORS FOR THE TREATMENT OF DISEASES | |
HUP0103113A3 (en) | New pharmaceutical compositions uses for nos inhibitors | |
HK1030552A1 (en) | Pharmaceutical compositions | |
GB9806487D0 (en) | Pharmaceutical compositions | |
HU9902296D0 (en) | Pharmaceutical composition for treating caltification | |
PL355625A1 (en) | Use of formulations for treating surfaces for temporarily improving dirt-removing behavior | |
HUP0202791A3 (en) | Pharmaceutical compositions for treating psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |